Early Detection of HCV in Injection Drug Users

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitute of Health Information and Statistics of the Czech Republic

About this trial

The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in the Czech Republic.

The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Hepatitis C and setting up and testing new methods and implementation into the system of social health care.

Eligibility criteria

Qualifiers

age 18+

an active injecting drug user or have used injecting drugs at any time in the past

Disqualifiers

not agreeing to participate in the project

Trial design

Treatments tested in this trial

  • Hepatitis C antibody (anti-HCV) test
  • Hepatitis C RNA test and genotype test

Treatment groups

3,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

Institute of Health Information and Statistics of the Czech Republic

Lead sponsor

Institute for Clinical and Experimental Medicine

Collaborator

Brno University Hospital

Collaborator

České Budějovice Hospital

Collaborator

University Hospital Hradec Kralove

Collaborator

University Hospital Olomouc

Collaborator

Hepatogastroenterology Hradec Kralove

Collaborator

Regional Hospital Karlovy Vary

Collaborator

Clinic Podane ruce

Collaborator

Tomáš Baťa Regional Hospital in Zlín

Collaborator

Hospital Agel Prostějov

Collaborator

Hospital Jihlava

Collaborator

Hospital Havířov

Collaborator

Hospital Tábor

Collaborator

Remedis Prague

Collaborator

Hospital Opava

Collaborator

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

Collaborator

Military University Hospital, Prague

Collaborator

Hospital Pardubice

Collaborator